J. Cooper

发表

Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study Groups

Martha Milanes-Yearsley, M. Hammond, T. Pajak, 2002, Modern Pathology.

CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

K. Ang, G. Cosnard, P. Levendag, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effective Immune Response In Patients Who Have Hematologic Malignancies After Vaccination with Inactivated Influenza A (H1N1) 2009 Monovalent Vaccine

J. Cooper, J. Treanor, T. Fitzgerald, 2010 .

Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

J. Jacobs, T. Pajak, J. Cooper, 2004, The New England journal of medicine.

Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382).

J. Cooper, T. Leong, H. Quon, 2011, International journal of radiation oncology, biology, physics.

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

R. Weber, T. Pajak, J. Cooper, 2003, The New England journal of medicine.

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Jay S. Cooper, Sharon A. Spencer, Christopher U. Jones, 1999 .

Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary

Steven S. Chang, J. Cooper, S. Yom, 2020, Head & neck.

The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.

Edward S. Kim, S. Lippman, F. Khuri, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Treatment of advanced laryngeal carcinoma.

C. C. Wang, J. Cooper, G. Laramore, 1991, The New England journal of medicine.

Results of Radiation Therapy Oncology Group 97-03—A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck: Long-term Results and Late Toxicities

Christopher U. Jones, A. Garden, J. Cooper, 2007 .

Feasibility of using administrative claims data for cost-effectiveness analysis of a clinical trial

J. Cooper, K. Fu, Mythreyi Bhargavan, 2008, Journal of medical economics.

The influence of dose on the long-term control of Classic (non-AIDS associated) Kaposi's sarcoma by radiotherapy.

J. Cooper, 1988, International journal of radiation oncology, biology, physics.

A Comparison of Survival Rates for Treatment of Melanoma Metastatic to the Brain

J. Golfinos, J. Cooper, K. Koenig, 2004, Cancer investigation.

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.

J. Cooper, B. Emami, V. Vaitkevicius, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG Study.

J. Cooper, R. Pazdur, R. Byhardt, 1988, International journal of radiation oncology, biology, physics.

Factors Associated with Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

A. Garden, K. Ang, R. Weber, 2008 .

Concomitant chemotherapy and radiation therapy certainly improves local control.

K. Ang, J. Cooper, 2005, International journal of radiation oncology, biology, physics.

LOCOREGIONAL THERAPY FOR RESECTABLE OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS

Christopher U. Jones, J. Cooper, S. Yom, 2016 .

Postoperative mediastinal radiation for cancer of the lung.

M. Gail, J. Minna, J. Cooper, 1987, The New England journal of medicine.

Conformal Therapy: Treatment Planning, Treatment Delivery, and Clinical Results

Charles R. Thomas, V. Budach, J. Cooper, 2013 .

TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.

A. Garden, K. Ang, W. Curran, 2007, The Lancet. Oncology.

National Cancer Database report on cancer of the head and neck: 10‐Year update

K. Ang, R. Weber, J. Cooper, 2009, Head & neck.

Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas.

J. Cooper, D. Pfister, J. Bernier, 2005, Critical reviews in oncology/hematology.

Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.

T. Pajak, J. Cooper, J. Beitler, 1997, International journal of radiation oncology, biology, physics.

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

Edward S. Kim, S. Lippman, F. Khuri, 2006, Journal of the National Cancer Institute.

Postoperative Management of High-Risk Resectable Head and Neck Cancer

J. Cooper, 2011 .

Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?

J. Cooper, J. Bernier, 2005, The oncologist.

How Strong Is the Evidence ? Chemoradiation after Surgery for High-Risk Head and Neck Cancer Patients :

J. Cooper, J. Bernier, 2005 .

Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: R.T.O.G. brain metastases phases I & II

R. Gelber, J. Cooper, H. Berry, 1978 .

Fraction size in external beam radiation therapy in the treatment of melanoma.

J. Cooper, W. Sause, S. Rush, 1991, International journal of radiation oncology, biology, physics.

Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.

B. Vikram, J. Cooper, K. Fu, 1998, International journal of radiation oncology, biology, physics.

Postoperative irradiation in head and neck cancer.

J. Cooper, 1993, International journal of radiation oncology, biology, physics.

Toxicity of oral radiotherapy in patients with acquired immunodeficiency syndrome.

J. Cooper, P. Fried, 1987, Archives of otolaryngology--head & neck surgery.

RETREATMENT OF RECURRENT HEAD AND NECK CANCER AFTER PRIOR DEFINITIVE RADIATION

J. Cooper, S. Yom, H. Quon, 2014 .

Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/intergroup phase III trial

J. Jacobs, T. Pajak, J. Cooper, 2002 .

Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma. Radiation therapy oncology group brain metastases study I and II

R. Gelber, J. Cooper, H. Berry, 1980, Cancer.

The evolution of the role of radiation therapy in the management of mucocutaneous malignant melanoma.

J. Cooper, Facr, 1998, Hematology/oncology clinics of North America.

Additional experience with empiric radiotherapy for presumed human immunodeficiency virus–associated primary central nervous system lymphoma

J. Cooper, J. W. Sullivan, B. Donahue, 1995, Cancer.

Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study.

J. Cooper, J. Hannigan, B. Sikic, 1990, Gynecologic oncology.

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

J. Cooper, B. Emami, V. Vaitkevicius, 1992, The New England journal of medicine.

Superiority of combined chemoradiotherapy to radiotherapy alone in patients with esophageal cancers. An intergroup study

J. Cooper, B. Emami, V. Vaitkevicius, 1994 .

Significant adbantage of chemo-radiotherapy compared to radiation alone in randomized phase III trial for patients with esophageal cancer: An intergroup study

T. Pajak, J. Cooper, B. Emami, 1991 .

Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis.

A. Garden, K. Ang, R. Weber, 2012, International journal of radiation oncology, biology, physics.

Seduction by induction?

J. Cooper, J. Beitler, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Head and neck cancer committee

R. Weber, F. Khuri, T. Pajak, 2001 .

Cancer of the Larynx and Hypopharynx

J. Cooper, 2008 .

Multimodality paradigms for a healthy multimodality society.

J. Cooper, 2002, Cancer journal.

Precisely defining high‐risk operable head and neck tumors based on rtog #85‐03 and #88‐24: Targets for postoperative radiochemotherapy?

K. Ang, J. Jacobs, T. Pajak, 1998, Head & neck.

Induction chemotherapy in advanced head and neck tumors.

J. Cooper, 1992, International journal of radiation oncology, biology, physics.

Training the radiation oncologist for the twenty-first century.

C. Coleman, J. Cooper, L. Prosnitz, 1996, International journal of radiation oncology, biology, physics.

Cerebral metastases: value of reirradiation in selected patients.

J. Cooper, A. Steinfeld, I. Lerch, 1990, Radiology.

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

J. Cooper, M. Graham, S. Spencer, 1999, JAMA.

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

K. Ang, J. Jacobs, T. Pajak, 2012, International journal of radiation oncology, biology, physics.

The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited

V. Grégoire, T. Pajak, J. Cooper, 2017, Cancer.

Reply to R.I. Haddad et al

J. Cooper, J. Beitler, 2009 .

Radiotherapy of intracerebral metastatic malignant melanoma.

J. Cooper, R. Carella, 1980, Radiology.

Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival

R. Weber, J. Cooper, A. Stewart, 2006, The Laryngoscope.

ACR appropriateness criteria® nasal cavity and paranasal sinus cancers

Christopher U. Jones, J. Cooper, S. Yom, 2017, Head & neck.

ACR Appropriateness Criteria® Aggressive Nonmelanomatous Skin Cancer of the Head and Neck

Christopher U. Jones, J. Cooper, S. Yom, 2016, Head & neck.

AGGRESSIVE NONMELANOMATOUS SKIN CANCER OF THE HEAD AND NECK Panel on Radiation Oncology–Head

Christopher U. Jones, J. Cooper, S. Yom, 2015 .

A role for radiotherapy in the treatment of solid and papillary neoplasms of the pancreas

J. Cooper, E. Balthazar, P. Fried, 1985, Cancer.

Selenium and immunocompetence in patients with head and neck cancer

J. Cooper, H. Hochster, R. Glickman, 2000, Biological Trace Element Research.

Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11.

R. Weber, J. Cooper, J. Ridge, 2003, Archives of otolaryngology--head & neck surgery.

Treatment of aggressive keratoacanthomas by radiotherapy.

J. Cooper, S. Rush, B. Donahue, 1990, Journal of the American Academy of Dermatology.

Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.

P. Rubin, T. Pajak, J. Cooper, 1989, International journal of radiation oncology, biology, physics.

Radiation Therapy for Kaposi’s Sarcoma

J. Cooper, 2004 .

Initial observations of the effect of radiotherapy on epidemic Kaposi's sarcoma.

J. Cooper, P. Fried, L. Laubenstein, 1984, JAMA.

Present role and future prospects for radiotherapy in the management of malignant melanomas.

A. Kopf, R. Bart, J. Cooper, 1979, The Journal of dermatologic surgery and oncology.

Radiation Treatment and Radiation Reactions in Dermatology

Jay S. Cooper, J. Cooper, R. Panizzon, 2004, Springer Berlin Heidelberg.

Defining the role of radiation therapy in the management of epidemic Kaposi's sarcoma.

J. Cooper, P. Fried, 1987, International journal of radiation oncology, biology, physics.

Radiation Therapy in the Treatment of Skin Cancers

J. Cooper, 2011 .

A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.

A. Garden, T. Pajak, J. Cooper, 2000, International journal of radiation oncology, biology, physics.

The duration of local control of classic (non-AIDS-associated) Kaposi's sarcoma by radiotherapy.

J. Cooper, J. Newall, J. Sacco, 1988, Journal of the American Academy of Dermatology.

Radiotherapy of malignant melanoma.

J. Cooper, 1985, Dermatologic clinics.

Case report. Treatment of aggressive epidemic Kaposi's sarcoma of the conjunctiva by radiotherapy.

J. Cooper, P. Fried, 1988, Archives of ophthalmology.

Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi's sarcoma.

J. Cooper, A. Steinfeld, I. Lerch, 1991, International journal of radiation oncology, biology, physics.

Epidemic and classic Kaposi's sarcoma of the feet. A comparative study.

J. Cooper, A. Steinfeld, 1990, Journal of the American Podiatric Medical Association.

The prognostic significance of residual pigmentation following radiotherapy of epidemic Kaposi's sarcoma.

J. Cooper, A. Steinfeld, I. Lerch, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimal treatment of epidemic Kaposi's sarcoma.

J. Cooper, 1990, International journal of radiation oncology, biology, physics.

Radiation therapy of malignant melanoma.

J. Cooper, 2002, Dermatologic clinics.

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.

W. Curran, R. Abrams, J. Cooper, 1995, International journal of radiation oncology, biology, physics.

Effect of combined adoptive immunotherapy and radiotherapy on tumor growth.

J. Cooper, M. Roy, H. Wishe, 1999, Radiation oncology investigations.

Late effects of radiation therapy in the head and neck region.

J. Cooper, K. Fu, S. Silverman, 1995, International journal of radiation oncology, biology, physics.

Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.

R. Weber, T. Pajak, J. Cooper, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Unique Case of Classic Kaposi's sarcoma restricted to the toes.

J. Cooper, D. Whitby, Yiwu Huang, 2013, Journal of dermatological case reports.

Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma.

K. Ang, J. Cooper, C. Chung, 2011, International journal of radiation oncology, biology, physics.

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.

A. Garden, C. Jones, J. Cooper, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)

M. Suntharalingam, J. Cooper, E. Sturgis, 2016, Cancer.

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

A. Garden, K. Ang, R. Weber, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.

J. Cooper, K. Greven, K. Winter, 2006, Gynecologic oncology.

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

Mitchell Morris, Patricia J Eifel, P. Grigsby, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic Extended-Field Irradiation of Para-aortic Lymph Nodes in Stages IIB and Bulky IB and IIA Cervical Carcinomas: Ten-Year Treatment Results of RTOG 79-20

P. Grigsby, T. Pajak, J. Cooper, 1995 .

Nasal Cavity and Paranasal Sinus Cancers

Christopher U. Jones, J. Cooper, S. Yom, 2016 .

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

M. van Glabbeke, J. Jacobs, J. Bourhis, 2005, Head & neck.

The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group.

R. Gelber, J. Cooper, L. Brady, 1981, International journal of radiation oncology, biology, physics.

Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG study

T. Pajak, J. Cooper, J. Ensley, 1987, Cancer.

Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90‐03

J. Cooper, K. Fu, D. Raben, 2006, Head & neck.

Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003).

K. Ang, M. Hammond, J. Cooper, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.

P. Grigsby, J. Cooper, M. Rotman, 1999, International journal of radiation oncology, biology, physics.

Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.

S. McDonald, T. Pajak, J. Cooper, 1994, International journal of radiation oncology, biology, physics.

A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases.

P. Rubin, J. Cooper, M. Rotman, 1992, International journal of radiation oncology, biology, physics.

Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report.

W. Curran, P. Rubin, T. Pajak, 1991, International journal of radiation oncology, biology, physics.

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long‐term results of the radiation therapy oncology group study 81‐17

W. Curran, T. Pajak, J. Cooper, 1990, Cancer.

Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study.

T. Pajak, J. Cooper, M. Mohiuddin, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial #79-15.

J. Cooper, C. Scott, T. Wasserman, 1989, International journal of radiation oncology, biology, physics.

Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial.

J. Cooper, S. Leibel, T. Wasserman, 1987, International journal of radiation oncology, biology, physics.

Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: an RTOG randomized trial.

J. Cooper, S. Leibel, T. Wasserman, 1986, International journal of radiation oncology, biology, physics.

Radiation Therapy for Malignancies in the Setting of HIV Disease

J. Cooper, B. Donahue, 2017 .

Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: a multivariate analysis of a multi-institutional experience.

J. Cooper, T. Hyslop, B. Corn, 1997, The cancer journal from Scientific American.

Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx-Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy.

T. Pajak, J. Cooper, J. Ensley, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Elective radiation therapy for high-risk malignant melanomas.

J. Cooper, D. Roses, R. Shapiro, 2001, Cancer journal.

Radiation Therapy Followed by Ipilimumab Is Appropriate.

J. Cooper, 2017, International journal of radiation oncology, biology, physics.

An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658).

Alicia Y Toledano, Jean B. Cormack, K Kian Ang, 2007, International journal of radiation oncology, biology, physics.

End of an era or not? That is the question--in response to Dr. J. M. Brown, IJROBP 32:883-885; 1995.

J. Cooper, K. Fu, T. Wasserman, 1995, International journal of radiation oncology, biology, physics.

A comparison of staging systems for nasopharyngeal carcinoma

J. Cooper, R. Stevens, R. Cohen, 1998, Cancer.

Brain metastases from malignant melanoma: conventional vs. high-dose-per-fraction radiotherapy.

J. Cooper, J. C. Ziegler, 1986, International journal of radiation oncology, biology, physics.

Locally advanced pancreatic cancer in a socio-economically challenged population

J. Cooper, B. Holland, Yiwu Huang, 2013 .

Malignant glioma. Results of combined modality therapy.

J. Cooper, J. Ransohoff, R. Carella, 1982, JAMA.

The Intergroup 0099 Trial for Nasopharyngeal Cancer: History, Perceptions, and Transitions

J. Cooper, 2010 .

Computerized (axial) tomography in the serial study of cerebral tumors treated by radiation. A preliminary report

J. Cooper, J. Newall, Irvin I. Kricheff, 1976, Cancer.

Palliation of AIDS-related primary lymphoma of the brain: observations from a multi-institutional database.

J. Cooper, B. Corn, W. Curran, 1997, International journal of radiation oncology, biology, physics.

Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer.

J. Cooper, T. Fitzgerald, Yiqing Xu, 2012, The oncologist.

Time course and significance of acute hyperamylasemia in patients receiving fractionated therapeutic radiation to the parotid gland region.

J. Cooper, T. Borok, 1982, International journal of radiation oncology, biology, physics.

Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.

J. Cooper, K. Greven, K. Winter, 2004, International journal of radiation oncology, biology, physics.

ACR Appropriateness Criteria® Locoregional therapy for resectable oropharyngeal squamous cell carcinomas

Christopher U. Jones, J. Cooper, S. Yom, 2016, Head & neck.

Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer

J. Cooper, K. Fu, W. Mckenna, 1996, Cancer.

Interobserver reliability of computed tomography‐derived primary tumor volume measurement in patients with supraglottic carcinoma

Alicia Y Toledano, K. Ang, J. Cooper, 2005, Cancer.

ACR Appropriateness criteria® for nasopharyngeal carcinoma

Christopher U. Jones, J. Cooper, S. Yom, 2016, Head & neck.

Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria

Steven S. Chang, J. Cooper, S. Yom, 2020, Head & neck.

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.

J. Jacobs, T. Pajak, J. Cooper, 1996, International journal of radiation oncology, biology, physics.

Nasopharyngeal Cancer: Multidisciplinary Management

J. Cooper, J. Lu, Wma Lee, 2010 .

Validation of the RTOG recursive partitioning classification for head and neck tumors

J. Cooper, K. Fu, B. Berkey, 2001, Head & neck.

Comparison of RPA‐derived staging and AJCC staging in head and neck cancers based on RTOG data

J. Cooper, K. Fu, B. Emami, 1996 .

Importance of MR technique for stereotactic radiosurgery.

J. Golfinos, J. Cooper, S. Rush, 2003, Neuro-oncology.

Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience.

J. Cooper, H. Hochster, H. Lee, 2000, International journal of radiation oncology, biology, physics.

Long Term Outcomes of RTOG 90–03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma

Sharon A. Spencer, Christopher U. Jones, J. S. Cooper, 2005 .

Phase II Trial of Combination Chemotherapy and Irradiation in Non‐Small‐Cell Lung Cancer, Radiation Therapy Oncology Group 88–04

J. Cooper, W. Sause, R. Lindberg, 1992, American journal of clinical oncology.

Pre-treatment and treatment related risk factors for severe late toxicity after chemo-RT for head and neck cancer: An RTOG analysis.

A. Garden, K. Ang, R. Weber, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.

Steven S. Chang, J. Cooper, S. Yom, 2022, International journal of radiation oncology, biology, physics.

RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/Taxol chemotherapy following surgery for patients with high-risk endometrial cancer

J. Cooper, K. Greven, T. Burke, 2004 .

Carcinoma of the uterine cervix: the Patterns of Care Study process survey.

J. Cooper, J. Sedransk, S. Kramer, 1979, International journal of radiation oncology, biology, physics.

Prophylactic cranial irradiation (PCI) for selected lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial

J. Cooper, J. Paradelo, A. Russell, 1990 .

Concurrent chemotherapy and radiation therapy for advanced stage carcinoma of the nasopharynx.

J. Cooper, J. Cooper, 2000, International journal of radiation oncology, biology, physics.

The use of digitally reconstructed radiographs for three-dimensional treatment planning and CT-simulation.

J M Galvin, J. Galvin, J. Cooper, 1995, International journal of radiation oncology, biology, physics.

Extracapsular tumor extension in cervical lymph nodes: Reconciling the literature and seer data

J. Cooper, A. G. Brannan, P. Johnstone, 2011, Head & neck.

Associations between Radiation Doses to Pharyngeal Regions and Severe Late Toxicity in Head and Neck Cancer Patients Treated With Concurrent Chemoradiotherapy–An RTOG Analysis

A. Garden, K. Ang, J. Galvin, 2007 .

Measuring the quality of medical care: a beginning.

J. Cooper, J. Sedransk, S. Kramer, 1979, Cancer clinical trials.

Feasibility of economic analysis of Radiation Therapy Oncology Group (RTOG) 91-11 using Medicare data.

K. Ang, J. Cooper, Mythreyi Bhargavan, 2011, International journal of radiation oncology, biology, physics.

The relationship of nasopharyngeal carcinomas and second independent malignancies based on the radiation therapy oncology group experience

J. Cooper, T. Griffin, G. Laramore, 1991, Cancer.

Regional Stage IV carcinoma of the nasopharynx treated by aggressive radiotherapy.

J. Cooper, J. Newall, J. D. Del Rowe, 1983, International journal of radiation oncology, biology, physics.

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

M. Leblanc, J. Cooper, K. Fu, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is mitomycin-c necessary in the chemoradiation regimen for anal canal carcinoma? interim results of a phase III randomized intergroup study

N. Petrelli, J. Cooper, L. Coia, 1993 .

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

J. Cooper, K. Fu, W. Sakr, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant fractionated high‐dose‐rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma

J. Cooper, T. Shakespeare, Jiade J. Lu, 2004, Head & neck.

2026 A comparison of RPA-derived staging and AJC staging in head & neck cancers based on RTOG data

J. Cooper, K. Fu, B. Emami, 1995 .

Preliminary analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/taxol chemotherapy following surgery for patients with high-risk endometrial cancer

J. Cooper, C. Moorthy, K. Greven, 2001 .

Chemoradiotherapy of Locally Advanced Esophageal Cancer: Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01)

J. Cooper, M. Graham, S. Spencer, 1999 .

ACR Appropriateness Criteria® Locoregional therapy for resectable oropharyngeal squamous cell carcinomas

Christopher U. Jones, J. Cooper, S. Yom, 2016, Head & neck.

Cancer of the Larynx and Hypopharynx

J. Cooper, 2008 .

RETREATMENT OF RECURRENT HEAD AND NECK CANCER AFTER PRIOR DEFINITIVE RADIATION

J. Cooper, S. Yom, H. Quon, 2014 .

Association of high Gli1 expression with poor survival in head and neck cancer patients treated with radiation therapy (RTOG 9003).

K. Ang, M. Hammond, J. Cooper, 2010 .

Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931.

M. Luu, J. Cooper, P. Harari, 2022, International journal of radiation oncology, biology, physics.

The use of digitally reconstructed radiographs for 3D treatment planning and CT-simulation

J. Galvin, J. Cooper, C. Sims, 1993 .

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes, NRG Oncology/RTOG 9501-0234.

M. Suntharalingam, J. Cooper, G. Laramore, 2015 .